Why is next-generation sequencing used in PGT-M?

PGT-M begins with a family-specific testing plan based on the gene change or condition being considered. After IVF, the laboratory takes a small biopsy from each embryo and analyses its DNA. Sequencing can read the relevant gene region and, when designed into the test, nearby markers that help interpret whether the embryo inherited the familial variant.

This is targeted testing rather than a general search for every genetic difference. A report may identify an embryo as unaffected, affected, a carrier, or inconclusive, depending on the condition and inheritance pattern. Technical limits, sample quality, and the small number of cells tested mean that follow-up testing in pregnancy may still be offered.

Meet a genetics professional before IVF to confirm the familial variant and discuss who in the family may need testing. Ask how long the laboratory preparation takes, which results can be reported, and what happens if no embryo gives a clear result. Your fertility team can explain embryo transfer choices, while a prenatal clinician can discuss testing after pregnancy begins.

Contact the fertility or genetics team if the PGT-M report is unclear, unexpected, or does not match the family history. They may need to review the test design or recommend another sample. During fertility treatment, seek urgent medical help for severe pelvic pain, heavy bleeding, fever, or breathing difficulty rather than waiting for genetic results.

Ask which variant is being tested, whether carrier status is included, how the inheritance pattern changes embryo interpretation, and whether prenatal confirmation is recommended. Clarify how inconclusive embryos are handled and who will explain the final report.